文献速递神经MR

定量磁共振成像与放射基因组生物标志物用于胶质瘤表征的系统综述

Quantitative magnetic resonance imaging and radiogenomic biomarkers for glioma characterisation: a systematic review.
PubMed 文献 · Br J Radiol · 2018-06-29

该系统综述检索2002至2017年Medline数据库,从249篇文献中纳入38篇,其中14篇涉及可量化影像参数、24篇涉及与影像关联的分子生物标志物。与多种影像表型相关的基因包括EGFR、MGMT、IDH1、VEGF、PDGF、TP53和Ki-67,其中EGFR研究最多(41.7%),其次为MGMT(20.8%)和IDH1(16.7%)。作者认为放射基因组学有助于理解肿瘤生物学和分子通路,某些与EGFR、MGMT、IDH1强相关的MRI特征可能作为影像生物标志物。

要点

  • 与影像表型相关的基因包括EGFR、MGMT、IDH1、VEGF、PDGF、TP53和Ki-67。
  • 所综述研究中EGFR是最常被研究与影像特征相关的基因(41.7%),其次为MGMT(20.8%)和IDH1(16.7%)。
  • 某些与EGFR、MGMT和IDH1强相关的MRI特征可能作为影像生物标志物。

核心结论

  • 放射基因组学有助于理解肿瘤生物学及潜在分子通路。
  • 某些与EGFR、MGMT和IDH1强相关的MRI特征可能作为影像生物标志物。
  • 了解肿瘤进展相关通路及其关联影像模式可能辅助诊断、预后和治疗管理,并促进个体化医疗。

研究设计与样本

  • 系统综述,检索2002至2017年Medline电子数据库发表的文献。
  • 共识别249篇题录,38篇符合纳入标准,其中14篇涉及可量化影像参数、24篇涉及与影像关联的分子生物标志物。

关键影像表现/征象

  • 可量化影像参数涉及异质性、血管性、扩散、细胞密度、浸润、灌注和代谢物改变。
  • 与影像表型相关的基因包括EGFR、MGMT、IDH1、VEGF、PDGF、TP53和Ki-67。
  • 综述汇总了胶质瘤形态学、基因表达、影像特征、预后和治疗反应之间的关系。

诊断标准与关键数值

  • 所综述研究中与影像特征相关的基因研究占比:EGFR 41.7%、MGMT 20.8%、IDH1 16.7%。

临床应用与阅片要点

  • 作者认为,某些与EGFR、MGMT和IDH1强相关的MRI特征可能作为影像生物标志物。
  • 作者认为,了解肿瘤进展相关通路及其关联影像模式可能辅助诊断、预后和治疗管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE:: The diversity of tumour characteristics among glioma patients, even within same tumour grade, is a big challenge for disease outcome prediction. A possible approach for improved radiological imaging could come from combining information obtained at the molecular level. This review assembles recent evidence highlighting the value of using radiogenomic biomarkers to infer the underlying biology of gliomas and its correlation with imaging features.

METHODS:: A literature search was done for articles published between 2002 and 2017 on Medline electronic databases. Of 249 titles identified, 38 fulfilled the inclusion criteria, with 14 articles related to quantifiable imaging parameters (heterogeneity, vascularity, diffusion, cell density, infiltrations, perfusion, and metabolite changes) and 24 articles relevant to molecular biomarkers linked to imaging.

RESULTS:: Genes found to correlate with various imaging phenotypes were EGFR, MGMT, IDH1, VEGF, PDGF, TP53, and Ki-67. EGFR is the most studied gene related to imaging characteristics in the studies reviewed (41.7%), followed by MGMT (20.8%) and IDH1 (16.7%). A summary of the relationship amongst glioma morphology, gene expressions, imaging characteristics, prognosis and therapeutic response are presented.

CONCLUSION:: The use of radiogenomics can provide insights to understanding tumour biology and the underlying molecular pathways. Certain MRI characteristics that show strong correlations with EGFR, MGMT and IDH1 could be used as imaging biomarkers. Knowing the pathways involved in tumour progression and their associated imaging patterns may assist in diagnosis, prognosis and treatment management, while facilitating personalised medicine.

ADVANCES IN KNOWLEDGE:: Radiogenomics can offer clinicians better insight into diagnosis, prognosis, and prediction of therapeutic responses of glioma.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Seow P, Wong JHD, Ahmad-Annuar A, et al. Quantitative magnetic resonance imaging and radiogenomic biomarkers for glioma characterisation: a systematic review. Br J Radiol. 2018. PMID: 29902076. doi:10.1259/bjr.20170930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。